In recent years, an expanding body of evidence has implicated protein phosphorylation as an important regulatory mechanism in the expression of neuronal plasticity (Gispen and Routtenberg, 1986) . A model system of neuronal plasticity in the adult brain, in which persistent alterations of synaptic efficacy may be measured electrophysiologically, is hippocampal long-term potentiation (LTP; Bliss and Lomo, 1973) . In this paradigm, the response of a population of dentate gyrus granule cells to a constant afferent volley can be increased for hours or days following high-frequency stimulation of the afferent fibers. Work from this laboratory has suggested that activation of the Ca*+/ phospholipid-stimulated protein kinase C (PKC; Takai et al., 1977 Takai et al., , 1979 , and consequent phosphorylation of one of its substrates, protein Fl (Akers and Routtenberg, 1985; Nelson and Routtenberg, 1985; Chan et al., 1986b) , may mediate the persistence, but not the initiation of the LTP response (see Akers et al., 1986; Lovinger et al., 1986; Routtenberg, 1986; Routtenberg et al., 1986 , for a review). Activation of PKC by the well-characterized, phospholipase C (PLC)-mediated diacylglycerol signal is known to absolutely require Ca2+ and phospholipid (see Nishizuka, 1986 , for a review). Work in our laboratory has shown that c&unsaturated fatty acids, such as oleate, can stimulate purified PKC directly in the absence of Ca2+ and phospholipid (Murakami and Routtenberg, 1985; Murakami et al., 1986) . Thus, Murakami and Routtenberg (1985) have suggested that a second transmembrane-signaling mechanism for PKC activation may involve c&-unsaturated fatty acid release from the 2-acyl position of phospholipids by the action of the Ca*+-dependent enzyme, phospholipase A, (PLA,).
We have observed that application of the c&unsaturated fatty acid oleate in the dentate hilus prior to 2 brief trains of highfrequency stimulation caused the potentiated response to persist and grow, whereas application of either the trans-unsaturated fatty acid elaidate or the carrier solution caused the response to decay to baseline levels within 120 min (Linden et al., 1986a) . We have proposed that c&unsaturated fatty acids induce a persistent response through activation of PKC. It was also proposed that such compounds are released by LTP procedures: a transient rise in intracellular Ca2+ following high-frequency stimulation (Krnjevic et al., 1986 ) may stimulate PLA,, thereby resulting in oleate liberation and consequent PKC stimulation.
In the present study, we explored the mechanism of cis-unsaturated fatty acid action on LTP by asking the following questions: Can oleate directly elicit LTP, or can it only act in concert with a process initiated by high-frequency stimulation? Does oleate enhance the LTP response through action at the synapse? Are there measurable changes in PKC activity present in cytosolic and membrane fractions (Kraft and Anderson, 1983) of oleate-and control-treated LTP animals? Will inhibition of PLA, hasten the decay of an otherwise persistent LTP response, and, if so, will this inhibition be oleate-reversible?
A portion of the present results has appeared recently in abstract form (Linden et al., 1986b) .
Materials and Methods
Recording. Adult, male Sprague-Dawley rats, weighing 150-200 gm, were obtained from Harlan Breeders. Animals were anesthetized with urethane, and a twisted-wire bipolar stimulating electrode was placed in the perforant path, the excitatory tract that projects from the entorhinal cortex to the dentate gyrus granule cells; specifically, the stimulating electrode was placed in the "bottleneck" of the perforant path (Lomo, 197 1) to activate entorhinaldentate synapses maximally (coordinates: 8.0 posterior, 4.5 lateral to bregma). A multibarreled micropipette for field potential recording and drug application was placed in either the hilus or the molecular layer of the dentate gyrus (coordinates: 4.0 posterior, 2.4 lateral to bregma), as guided by the perforant pathevoked response. The local potential recorded in the molecular layer is seen as a positive-going population spike superimposed on a negativegoing population EPSP. Both components of this response reverse as the recording electrode is advanced ventrally into the granule cell layer and dentate hilus (Andersen et al., 1966) . Recordings in the molecular layer were made at the point of maximal EPSP slope response, approximately 200 pm dorsal to the null zone. Likewise, hilar recordings were made at the point of maximal response in that zone, which was approximately 300 pm ventral to the null zone.
Drugs. The unsaturated fatty acids applied were oleate (cis-9-octadecenoate, Na+-free; Aldrich) and elaidate @runs-9-octadecenoate, Na+-free; Sigma). These compounds were directly dispersed into 20 mM Tris buffer, vigorously vortexed for 30 set, nitrogen-bubbled and sonicated for 10 min (Murakami and Routtenberg, 1985) to yield a concentration of 5.2 mM in the pipette. The PLA, inhibitor, mepacrine (Sigma), was dissolved in 20 mtvr Tris to yield a concentration in the pipette of 67.6 rnM.
Drug application. Separate barrels for recording (filled with normal saline), fatty acid application, and mepacrine application were used. Fatty acids were applied by iontophoresis. A 10 nA anodal backing current was used to prevent leakage. The following time/cathodal current parameters were used to achieve different oleate doses: 38 pmol-25 nA, 1 min; 76 pmol-25 nA, 2 min; 193 pmol-25 nA, 5 min; 587 pmol-25 nA, 15 min; 1435 pmol-38 nA, 15 min; 2569 pmol-50 nA, 15 min. Ejections of W-oleate were used to quantify fatty acid release. Release of elaidate was not directly quantified. Previous studies (Linden et al., 1986a, and unpublished observations) have shown that release of the unsaturated fatty acids oleate and arachidonate is not significantly different across a wide range of time/current parameters.
It is difficult to determine the precise local concentration of a drug applied in vivo. However, making the order-of-magnitude assumption that the ejectate (in nanoliter volumes) is contained within 5 ~1 of hippocampal tissue, the following rough estimates of in viva concentration may be derived: 38 pmol = 7.6 PM; 76 pmol = 15.2 PM; 193 pmol = 38.6 PM; 587 pmol = 117.4 PM; 1435 pmol = 287.0 PM; and 2569 pmol = 5 13.8 PM.
pacrine-containing barrel with an mterpulse interval of 5 set, and the ejection volume was quantified by direct microscopic observation of the fluid miniscus within the barrel. Observation of the miniscus was Mepacrine was applied through a micropressure ejection system (design courtesy of Dr. J. Feldman; described in McCrimmon et al., 1986 ). Pulses of 20 msec duration. 5 nsi nressure were delivered to the meuncontaminated by population spike effects after high-frequency stimulation.
Groups of 5 consecutive waveforms were analyzed on-line to produce the final waveforms used for analysis. Population spike amplitude and population EPSP slope were measured as previously described . These measures were normalized across subjects by conversion to percentage of baseline values. The baseline value was the first data point recorded after a 45 min period in which the response was allowed to stabilize following electrode placement.
High-frequency stimulation to induce LTP was delivered using 8 pulse trains at 400 Hz, 0.4 msec pulse width, and voltage at threshold plus 4 V. In this report, "high-frequency stimulation" refers to the above parameters, while "low-frequency stimulation" refers to 0.1 Hz, 0.1 msec pulse width. Either 2 or 8 of these high-frequency trains were delivered, with a 30 set intertrain interval, to induce LTP. Eight trains have been demonstrated to produce LTP lasting for at least 120 min, whereas 2 trains have been shown to produce a response that persists for 30 min and then decays to baseline within 120 min (Linden et al., 1986a; Routtenberg et al., 1986) . The duration of the potentiation induced by 2 trains is significantly longer than that of posttetanic potentiation (McNaughton, 1982) and consequently is likely to represent a different phenomenon. Test pulses were delivered for 120 min following highfrequency stimulation, after which the brain was quickly frozen in situ by immersion of the animal in liquid nitrogen to prepare for subsequent biochemical analysis. Each experimental group contained 4 animals.
PKC distribution assay. The region of the dorsal hippocampus where the fatty acids were applied was dissected in the cold room (4°C) and homogenized with 40 vol of buffer [50 mM Tris, 0.1 mM EDTA, 2 mM dithiothreitol (DTT), 10 pg/rnl leupeptin, pH 7.5, at 4"C] in a custommade plastic homogenizer (20 up-and-down strokes). Homogenate (300 J) was centrifuged at 100,000 x g for 1 hr at 4°C and the supematant was saved as the PKC cytosol fraction. PKC associated with the pellet was solubilized in buffer (50 mM Tris, 1 mM EDTA, 1 mM EGTA, 2 mM DTT, 1% Triton X-100,lO j&ml leupeptin) for 1 hr at 4°C followed by a 100,000 x g spin for 1 hr. The resultant supematant was collected as the PKC membrane fraction. Both cytosolic and membrane fractions were applied to DEAE-cellulose minicolumns to eliminate the effect of inhibitors or phospholipid contamination.
This minicolumn was preeauilibrated with 2 ml of column buffer (50 mM Tris. 1 mM EDTA. 1 n&r EGTA, 2 mM DTT, pH 7.5, at 4"C), washed twice with 1 ml'of buffer containing 50 mM Tris, 1 mM EGTA, and 2 mM DTT (pH 7.5 at 4°C). and the PKC was eluted with 500 ~1 of buffer containine 0.25 M KCl; 50 mM Tris, 1 mM EGTA, and 2.m~ DTT (pH 7.5 at-CC). PKC activity was measured as previously described (Murakami and Routtenberg, 1985) .
Results
repeated throughout the course of the experiment to ensure that no leakage occurred. The volume of the ejectate was 7.4 nl, and the amount was 500 pmol. Estimating the concentration in vivo by the method described above yields a value of 100 FM. This target concentration was chosen because a previous study had shown that 100 NM mepacrine was the lowest concentration that would produce maximal PLA, inhibition (-80%) as measured by arachidonate release (Mallorga et al., 1980) . In contrast, it has been demonstrated in our lab that 100 PM mepacrine will cause a minimal lO-15% inhibition of Durified PKC activation induced by oleate in the presence or absence of Ca2+ (K. Murakami, unpublished observations).
If oleate application acts synergistically with the consequences of 2 high-frequency trains to produce a persistent LTP response, Synergism between oleate application and high-frequency then it could be predicted that neither oleate nor 2-train stimulation would produce a persistent facilitation of synaptic transstimulation mission when applied alone.
Data acquisition and analysis. Test pulses were delivered at 0.1 Hz with a 0.1 msec pulse width. To allow for a physiologically relevant comparison across subjects, threshold was defined for each subject as the lowest-integer-stimulation voltage at which a population spike was evoked prior to high-frequency stimulation or drug application. For hilar recording, in which spike amplitude was the relevant measure, the test voltage was threshold plus 2 V. This stimulation typically yields a response in which the spike amplitude is one-third of the EPSP amplitude, a condition previously shown to be optimal for demonstrating LTP . For molecular layer recording, in which EPSP slope was the relevant measure, the test voltage was threshold minus 2 V. This stimulation yields a population EPSP that will remain To test this prediction, the following within-animal design was used. Each of 4 groups had a recording/drug application electrode placed in the dentate hilus. Two groups received a single drug ejection (oleate or Tris) at t = 0 (120 min prior to high-frequency stimulation). The other 2 groups received 2 drug ejections, first at t = 0 and then just prior to high-frequency stimulation at t = 120. All 4 groups had 2 high-frequency trains delivered at t = 135. The dose ofoleate delivered in each ejection was 1435 pmol, which has previously been shown to prolong the potentiated response produced by 2 high-frequency trains for 120 min (Linden et al., 1986a) . This double-injection design allowed us to evaluate oleate effects in the same animal both in the absence ofand in conjunction with 2 trains ofhigh-frequency stimulation. Ejection of 1435 pmol of oleate into the dentate hilus in the absence of high-frequency stimulation did not affect the baseline population spike amplitude response ( Fig. 1 
, t = O-120 min).
A 2-way analysis of variance (ANOVA), including all 4 groups across the time segment t = O-l 20, indicated no significant effect of drug treatment on the baseline response (F= 1.46, df = 3,108, p > 0.20). The potentiated response (t = 135-240) was seen to persist and grow with application of oleate at t = 0 and t = 120 (immediately before the high-frequency stimulation); the response following all 3 other treatments, including the single oleate ejection at t = 0, decayed to baseline at t = 240. A 2-way ANOVA, including all 4 groups, from t = 135 to t = 240, indicated a significant effect ofdrug treatment on the potentiated response (F = 8.09, df= 3,96, p < 0.00 1). In addition, the initial magnitude of potentiation measured at t = 135 was not significantly affected by any of the drug treatments (F = 2.67, df = 3,12, p > 0.05).
In sum, oleate ejection in conjunction with high-frequency stimulation produced a persistent potentiated response while leaving the initial magnitude of potentiation unaltered; oleate ejection alone in the hilus was ineffective in altering baseline synaptic transmission, and oleate ejection 120 min prior to highfrequency stimulation was ineffective in producing a persistent potentiated response. Thus, it would appear that a persistent potentiated response requires oleate application together with 2 high-frequency trains, that the persistent response so induced is not an additive, but rather a synergistic, effect of separate oleate and 2-train responses, and that the influence of oleate on LTP persistence cannot be ascribed to an effect on the initiating component of LTP.
Dose-response function in the dentate hilus To determine whether the lack of response to oleate alone was a dose-related effect, 4 groups of animals received different doses of oleate applied in the dentate hilus, using the same doubleinjection protocol described above and illustrated in Figure 1  (Fig. 2) .
Oleate alone, at all 4 doses tested, had no effect on the spike amplitude measure in the period t = O-120 (F = 0.72, df = 3,108, p > 0.25). However, following the second ejection of oleate, the highest dose, 2569 pmol, was seen to significantly impair the initial magnitude of potentiation at t = 135 (F = 5.50, df = 3,12, p -C 0.025). One-way ANOVA tests run among pairs of groups at this time point yielded significant differences between 193 and 2569 pmol (F = 34.89, df = 1,6, p < 0.005) and between 587 and 2569 pmol (F = 15.89, df = 1,6, p < 0.0 1). No differences among the other 3 dose groups were found (all p > 0.25).
A U-shaped dose-response curve was observed on the time course of the potentiated response; both the lowest (193 pmol) and the highest (2569 pmol) doses failed to induce a persistent response. The 1435 pmol dose alone caused the response to persist, and the 587 pmol dose appeared to slow the response decay process. These observations are supported by a significant effect of dose across t = 135-240 (F = 9.15, df = 3,96, p < 0.001).
Dose-response function in the dentate molecular layer If the prolongation of the LTP response produced by oleate application in the hilus is a result of action at perforant path synapses, then the dose required to prolong the LTP response should be lower for oleate application in this synaptic terminal zone. To test this hypothesis, each of 6 groups received different doses of oleate applied in the molecular layer at the region of maximal negativity, as measured by EPSP slope. The protocol for timing of ejections and high-frequency stimulation was identical to that used in determining the hilar dose-response function. No effect of dose on the baseline population EPSP slope was seen following the first ejection (F = 0.62, df = 5,162, p > 0.25). The initial magnitude of potentiation was seen to be 3 . drastically reduced at the 2 highest doses; at 1435 pmol, potentiation was completely inhibited, and at 587 pmol it was reduced to approximately 40% of the Tris control value (Fig. 3) . The 193 pmol dose was the most effective in prolonging the potentiated response; application of 76 pmol of oleate slightly retarded the response decay. A 2-way ANOVA, including all 6 groups, across t = 135-240 showed a significant effect of dose (F = 15.91, df = 5,144, p < 0.001). Furthermore, when the ANOVA was restricted to the 4 groups that showed unimpaired initial potentiation (the 4 lowest doses), the effect of dose remained significant (F = 12.07, df = 3,96, p < 0.001).
To compare the dose-response functions for molecular layer and hilar application, the responses at t = 240 are plotted as a function of dose (Fig. 4) . Since the y-axis is the population EPSP slope measure for the molecular layer records and the population spike amplitude measure for the hilar records, absolute heights of the 2 response functions should not be compared. However, it is clear that the dose-response functions for both loci have the shape of an inverted I-l, and that the optimal dose applied to the molecular layer is lower than the dose applied to the hilus.
Measurement of PKC activity: oleate/high-frequency synergism Since oleate, a PKC activator, prolongs LTP responses when applied together with 2 high-frequency trains, but has no effects on baseline synaptic transmission when applied alone, one would predict that PKC activation is not altered following oleate ejection alone, but would be when oleate was applied in conjunction with high-frequency stimulation. If PKC activation were the mechanism through which oleate enhancement of LTP were mediated, then it could be predicted that alterations of PKC would parallel the electrophysiological responses produced by oleate and high-frequency stimulation, alone and in combination.
Protein kinase C assays following oleate ejection alone Two groups received an ejection of 193 pmol of oleate into the dentate molecular layer, following which perforant path-evoked responses were monitored at low frequency for 1 or 5 min, at which point the animals were killed and the assay conducted. In addition, a control group received no ejection and was killed after receiving 120 min of test pulses. No significant differences in PKC activity could be seen across groups when measured in homogenate, or separated, cytosolic (C) and membrane (M) fractions (all p > 0.25; see Table 1 ). Also, the index of PKC distribution, M/(C + M), showed no significant alteration in localization of the PKC activity as a consequence of oleate ejection (p > 0.25). Thus, no alteration of PKC activity was observed as a consequence of oleate ejection.
Protein kinase C assays following oleate-enhanced LTP Three groups received either oleate (193 pmil), elaidate, or Tris ejections into the dentate molecular layer, followed by 2 highfrequency trains to induce LTP, animals were killed 60 min following the trains. Synaptic responses were monitored until the time of death. Tissue from these 3 groups was subjected to an assay of PKC activity. PKC activity was increased in the membrane and decreased in the cytosol of the oleate group (Table 1) . It may also be seen that the PKC activity of the combined (C + M) fractions and the homogenate (H) was not altered. Taken together, these data indicate that PKC activity was translocated to the membrane in the oleate group. This is supported by a significant increase in the M/(C + M) measure of the oleate group compared to the Tris group (F = 7.53, df = 1,6, p < 0.05; ANOVA). The percentage of PKC activity in the membrane [M/(C + M)] is also significantly correlated with the percentage of baseline population EPSP slope measure just prior to death (r = +0.760, df = 10, p < 0.01).
Mepacrine effects on LTP Inhibition of a persistent LTP response. If endogenous oleate release were critical for producing a persistent LTP response, then it could be predicted that blockade of the enzyme responsible for that release would inhibit the time course of the response. To test this prediction, each of 3 groups was implanted with recording/drug application electrodes in the dentate molecular layer. Two groups received ejections of either mepacrine, a PLA, inhibitor, or a Tris control solution (at t = -5) followed by 8 trains of high-frequency stimulation (Fig. 5) . The third group received no ejection prior to the trains, but rather an ejection of mepacrine 5 min following the end of the trains. Eight trains of high-frequency stimulation typically produce a response that persists for at least 120 min, thus allowing an inhibition of the potentiated response to be detectable. No effect of drug treatment on the initial magnitude of potentiation was seen, as measured by population EPSP slope (F = 0.86, df= 2,9,p > 0.25). Mepacrine applied immediately before, but not immediately after, the high-frequency stimulation was seen to drastically inhibit the persistence of the potentiated response, causing it to decay almost to baseline within 120 min. This observation is supported by a 2-way ANOVA, including all 3 groups, across t = O-120 that yields a significant effect of treatment (F = 12.76, a!!= 2,8 1, p -C 0.001).
Oleate reversal of mepacrine efects If the inhibition of the LTP time course produced by mepacrine is due to inhibition of PLA,-mediated oleate release, then one would expect that this inhibition could be reversed by oleate. Thus, each of 4 groups received an ejection of mepacrine into the molecular layer, followed immediately by 8 high-frequency trains. Four different procedures were undertaken to attempt to reverse the previously demonstrated mepacrine inhibition of the potentiated response. First, 193 pmol of oleate was ejected immediately prior to the mepacrine ejection. Second, using the same ejection parameters (25 nA, 5 min), elaidate, the transstereoisomer of oleate, was ejected immediately prior to the mepacrine ejection. Third, 193 pmol of oleate was ejected 5 min after the end of the high-frequency trains (10 min after mepacrine ejection). Fourth, 193 pmol of oleate was ejected 70 min after the end of the high-frequency trains (75 min after mepacrine ejection).
Of these 4 treatments, only oleate application immediately before mepacrine ejection reversed the mepacrine inhibition of the potentiated response (Fig. 6) . Within the 120 min monitoring period, this reversal of the mepacrine effect was total; a significant effect of treatment was seen across t = O-120 (F = 19.73, df = 3,108, p < 0.001). Furthermore, 2-way ANOVAs run among pairs of the 3 groups that failed to show mepacrine reversal yielded no significant effect of treatment (p > 0.25 for all).
Discussion
Calcium and PKC as synergistic signals It has been proposed that intracellular Ca2+ and activation of PKC act synergistically to trigger prolonged hormone release in a number of non-neural systems (Kaibuchi et al., 1983; Michell, 1983; Kojima et al., 1984; see Nishizuka, 1986 , for a review). Recently, we have proposed an analogous model, in which intracellular Ca2+ and PKC act synergistically to produce a persistent LTP response (Routtenberg, 1986) . This model was based on the finding that neither the application of PKC-activating phorbol ester nor 2 trains of high-frequency stimulation alone could produce a persistent LTP response, but that when the 2 were applied together, a persistent LTP response was observed . In addition, no difference in the initial magnitude of potentiation was seen between groups receiving phorbol ester plus 2-train stimulation and the carrier solution plus 2-train stimulation. The above findings, together with the lack of alteration in PKC or its substrates immediately following high-frequency stimulation (Akers et al., 1986; Lovinger et al., 1986) , suggested that PKC modulates the duration of the LTP response, and that a Ca2+ influx produced by the 2-train stimulation initiates the LTP response through non-PKC mechanisms. An initial report using oleate in place of phorbol ester demonstrated the same synergism with the consequences of 2 highfrequency trains (Linden et al., 1986a) . The results herein confirm and extend this synergism model. across all the doses tested, both in hilus and molecular layer (Figs. l-3 ). Two trains of high-frequency stimulation alone did not produce long-lasting effects, but when oleate and 2-train stimulation were given together, they acted synergistically to produce a persistent potentiated response. What is the biochemical basis of this electrophysiological synergism? It has been reported that activation of PKC in viva may be dependent upon translocation of the kinase from the cytosol to the phospholipid environment of the membrane (Kraft and Anderson, 1983) . If oleate applied in the absence of high-frequency stimulation was incapable of translocating PKC, then this might serve to explain why oleate does not affect low-frequency synaptic transmission.
Application of oleate (at a dose known to enhance the potentiated response produced by 2 trains of high-frequency stimulation) was not seen to alter PKC distribution or total PKC activity when measured 1 or 5 min after ejection. This is consistent with the above hypothesis. It is possible that oleate activates PKC with a delay of greater than 5 min after the end of the ejection. However, preliminary evidence from this laboratory has suggested that oleate alone did not induce PKC activation/redistribution 30 or 120 min after ejection (D. J. Linden, F. S. Sheu, and A. Routtenberg, unpublished observations). When PKC distribution is assayed 60 min after oleate application together with 2 trains of high-frequency stimulation, PKC activity is translocated to the membrane relative to Tris and elaidate control groups. This suggests that oleate enhancement of 2-train LTP is mediated by persistent PKC activation. It is possible that the PKC translocation measured 60 min after oleate ejection plus 2-train stimulation is produced by ejected free oleate acting on PKC during the assay, rather than in vivo.
However, this is unlikely, as exogenous free oleate has been reported to be maximally incorporated into phospholipid within 15 min (Yoshioka et al., 1986) .
To explain the physiological and biochemical data observed, we propose that (1) oleate alone is incapable of translocating PKC; (2) 2 trains of high-frequency stimulation alter PKC, rendering it oleate-sensitive; (3) oleate applied in conjunction with 2 trains produces a strong activation/persistent translocation of PKC, (4) the strongly activated (translocated) PKC phosphorylates substrates (e.g., protein Fl) that mediate the persistent potentiated response. Thus, a strong or persistent activation of PKC is required to produce a persistent LTP response, and, consequently, neither 2-train stimulation nor oleate alone is sufficient. However, since PKC acts through phosphorylation of substrates, it is not necessary that PKC remain activated or translocated for the duration of the potentiated response.
We propose a hypothetical model in which 2-train stimulation renders PKC oleate-sensitive, but not strongly activated, thus priming PKC for activation by oleate. This is a refinement of our previously stated synergism model, which proposes that 2 trains act on non-PKC mechanisms to mediate the initiation of the LTP response. The present model proposes that 2-train stimulation initiates LTP through non-PKC mechanisms, and primes PKC by rendering it oleate-sensitive.
The action of 2-train stimulation on PKC that renders it oleate-sensitive may involve a weak/transient translocation of PKC to the membrane, which is then stabilized by the addition of oleate. Alternatively, 2-train stimulation may act on cytosolic PKC to render it oleate-sensitive in a manner that does not require any form of translocation. It should be noted that assays of PKC distribution following homogenization in the presence of chelators may strip loosely associated PKC from the membrane; consequently, the cytosol/membrane partition reported may actually be measuring a distinction between loosely and strongly membrane-associated PKC. However, if strongly associated PKC is the activated form, this does not require that the present model be altered.
Oleate has been reported to stimulate hydrolysis of phosphatidylinositides (Irvine et al., 1979) a process that results in release of diacylglycerol and inositol-1,4,%triphosphate and consequent PKC activation. Could the oleate applied in these studies be acting on PKC by stimulating diacylgylcerol release rather than by direct activation? Half-maximal stimulation of phosphoinositide hydrolysis required 1.5 mM oleate, while the estimated dose of oleate applied in vivo (to enhance 2-train potentiation) was approximately 37-fold lower. Thus, it appears unlikely that oleate stimulation of diacylglycerol release mediates the PKC activation observed in this report.
Oleate may activate PKC in a d$erent manner from that of phorbol esters
The observation that PKC-activating oleate does not alter synaptic transmission when applied alone is in contrast to a report (Malenka et al., 1986) using the PKC-activating phorbol ester (Castagna et al., 1982) , phorbol dibutyrate (PDBu). Bath-application of a large dose of PDBu (10 FM) to hippocampal slices was shown to increase synaptic transmission at the Schaffercollateral-CA1 synapse. This distinction may represent a difference in the properties of oleate and PDBu, or it may merely be indicative of differences in the regions studied (CA1 versus dentate gyrus), preparation used (slice versus intact), and method of drug application (bath versus local iontophoresis).
It is likely that there are significant distinctions in the mode of action of oleate (present study) and phorbol ester . First, though both prolong LTP, phorbol esters have been reported to translocate PKC activity from the cytosol to the membrane in the process of activation (Kraft and Anderson, 1983 ) while oleate has not been seen to have this effect in the present study. In the context of the model presented above, it would be predicted that when PDBu translocates PKC activity, it would produce at least a transient enhancement of synaptic transmission.
Second, phorbol esters have been reported to be resistent to metabolic alteration, and consequently may be able to enhance synaptic transmission through continual activation of PKC over many minutes, while oleate is metabolized much more quickly; it may be seen that hilar ejection of oleate 120 min prior to delivery of 2 high-frequency trains failed to induce a persistent potentiated response, as is observed when oleate is applied immediately prior to the trains (Fig. 1) . This implies that ejected oleate is metabolized, or incorporated into phospholipid, within 120 min, rendering it unavailable to act synergistically with high-frequency stimulation.
Locus of oleate action
For both hilar and molecular layer application of oleate, there was a most effective dose for prolonging the potentiated response. The effective dose in the molecular layer (193 pmol) was about 7-fold lower than the effective dose in the hilus, suggesting that oleate is acting at the site of the terminals, rather than at the cell body layer (Fig. 4) . This result is consistent with the hypothesis that oleate enhancement of LTP is mediated through PKC activation at the perforant path-granule cell synapses, since PKC has been reported to be enriched in synaptic membrane . It has also been reported that PKC in the perforant path-granule cell synapse is localized to the presynaptic terminal (Worley et al., 1986) , which implies that the action of PKC in LTP is on presynaptic functions (Routtenberg, 1985) .
The highest doses of oleate applied in both the hilus and molecular layer inhibited the initial magnitude of potentiation (Figs. 2, 3 ) although these doses had no effect on baseline synaptic transmission when applied 120 min previously in the same animals. This result suggests that high concentrations of oleate can more easily disrupt processes that underlie a potentiated response than those that mediate baseline synaptic transmission. The mechanism by which these high doses of oleate inhibit potentiation is unknown. It is possible that this inhibition is a consequence of a generalized disruption or fluidization of the membrane, which has previously been reported following application of large doses of oleate (Hanski et al., 1979) . In addition, recent work in our laboratory has shown that high concentrations of oleate can inhibit the phosphorylation of purified protein Fl by purified PKC in vitro, in the absence of membrane phospholipids (Chan et al., 1986a) .
Role of phospholipase A, in LTP Previous data from this laboratory have shown PKC activators such as oleate (Linden et al., 1986a ) and phorbol-12-myristate-13-acetate (TPA) to prolong the duration, but not affect the initial magnitude, of LTP, suggesting that PKC activation does not mediate the initiation of LTP, but rather the persistence of potentiated response. This notion is strengthened by the present finding that application of the PLA, inhibitor, mepacrine, immediately prior to 8 trains of highfrequency stimulation was seen to inhibit the persistence but not the initial magnitude of the potentiated response (Fig. 5) . Thus, it is suggested that mepacrine inhibits the time course of the potentiated response by blocking PLA,-mediated oleate liberation and consequent PKC stimulation.
That mepacrine application immediately following high-frequency stimulation does not alter the potentiated response is indicative of 2 phenomena. First, this result suggests that the previously noted mepacrine inhibition of the persistent potentiated response if not merely a result of nonspecific "poisoning" of synaptic transmission. Second, it indicates that there is a time window for the mepacrine inhibition of the LTP response, which is that PLA, activity concomitant with other immediate consequences of high-frequency stimulation is critical for mediating the persistence of LTP.
There are many PLA, inhibitors, but none of them, including mepacrine, p-bromophenacylbromide, tetracaine, chloroquine, and manoalide, are highly specific with regard to other phospholipases (Best et al., 1984; Glaser and Jacobs, 1986 ; R. S. Jacobs, personal communication). To address this issue, we were able to reverse the inhibitory effect of mepacrine selectively with oleate. Application of oleate immediately prior to mepacrine ejection, but not 5 or 70 min after high-frequency stimulation, was effective in completely reversing the mepacrine inhibition of the potentiated response (Fig. 6 ). This result is important in that it suggests that the mepacrine inhibition of the potentiated response is mediated through its inhibition of PLA,. In addition, it is significant that application of elaidate, the trans-stereoisomer of oleate, which is an ineffective PKC activator (Murakami and Routtenberg, 1985) failed to reverse the mepacrine effect. Thus, it appears that the oleate reversal of the mepacrine effect is dependent on its PKC-activating properties, rather than on either dilution of the mepacrine in vivo, or some nonspecific effect of fatty acids on the membrane. It should also be noted that mepacrine, in the concentration applied, has a minimal inhibitory effect on purified PKC, as measured in vitro (10.4%; K. Murakami, unpublished observations) .
In addition to the present proposed PLA,-mediated release of c&unsaturated fatty acids to stimulate PKC, PKC may also function in turn to modulate PLA, activity. Lipocortin, an endogenous PLA, inhibitor (Hirata et al., 1982) , is a PKC substrate and its activity may be modulated by phosphorylation (Hirata et al., 1984; Toqui et al., 1986) .
In the absence of exogenous substances, 2-train stimulation produces a response that decays to baseline within 120 min, while g-train stimulation produces a response that persists and grows. What is the molecular distinction that underlies these different responses? We propose that endogenous oleate release by the Ca*+-dependent enzyme PLA, functions to mediate the persistent LTP response produced by g-train stimulation. Two trains of high-frequency stimulation produce changes in PKC that only render it oleate-sensitive, not strongly active, and thus produce an LTP response that decays to baseline values within 120 min. However, 8 trains of high-frequency stimulation produce a sustained increase in intracellular CaZ+ (Kmjevic et al., 1986 ) that stimulates both (1) processes that render PKC oleatesensitive and (2) PLA,-mediated liberation of free oleate and other c&fatty acids from the 2-acyl position of membrane phospholipids.
In addition, while oleate activation of PKC is Ca2+-independent at high concentrations of oleate, low concentrations of oleate show Ca2+-dependent activation of PKC when either histone or purified protein Fl (Chan et al., 1986, and unpublished observations) is used as a substrate. Thus, free oleate could act on PKC to cause strong/persistent PKC activation, which is a prerequisite for a prolonged LTP response.
